Abiopharma

LTM lanza BlueVerse™ en Databricks para acelerar la monetización de la IA

GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis

LTM lanceert BlueVerse™ on Databricks om de monetisatie van AI te versnellen

LTM lance BlueVerse™ sur Databricks pour accélérer la monétisation de lIA

LTM lancia BlueVerse™ su Databricks per accelerare la monetizzazione dellAI

COSCIENS Biopharma Inc. Announces Results of Shareholder Meeting and Appointment of Full-Time CEO

Schrödinger, Inc. - Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

LIXTE Biotechnology Provides Update on NOMAD Acquisition; Transaction Expected to Close On or About July 1, 2026

MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University

Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit